Goldman Sachs Group Inc Treace Medical Concepts, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 464,804 shares of TMCI stock, worth $4.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
464,804
Previous 665,152 30.12%
Holding current value
$4.36 Million
Previous $3.86 Million 10.34%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$4.66 - $8.78 $933,621 - $1.76 Million
-200,348 Reduced 30.12%
464,804 $3.46 Million
Q3 2024

Nov 14, 2024
BUY
$5.01 - $8.45 $2.08 Million - $3.52 Million
416,060 Added 167.03%
665,152 $3.86 Million
Q2 2024

Aug 13, 2024
BUY
$4.17 - $12.62 $630,228 - $1.91 Million
151,134 Added 154.28%
249,092 $1.66 Million
Q1 2024

May 15, 2024
SELL
$11.48 - $15.86 $2.93 Million - $4.05 Million
-255,564 Reduced 72.29%
97,958 $1.28 Million
Q4 2023

Feb 13, 2024
BUY
$6.03 - $12.88 $1.4 Million - $2.98 Million
231,471 Added 189.65%
353,522 $4.51 Million
Q3 2023

May 14, 2024
SELL
$12.16 - $24.87 $2.81 Million - $5.76 Million
-231,471 Reduced 65.48%
122,051 $1.6 Million
Q3 2023

Nov 14, 2023
BUY
$12.16 - $24.87 $64,606 - $132,134
5,313 Added 4.55%
122,051 $1.6 Million
Q2 2023

May 14, 2024
SELL
$23.91 - $27.81 $166,485 - $193,641
-6,963 Reduced 5.63%
116,738 $2.99 Million
Q2 2023

Aug 14, 2023
SELL
$23.91 - $27.81 $166,485 - $193,641
-6,963 Reduced 5.63%
116,738 $2.99 Million
Q1 2023

May 14, 2024
BUY
$20.23 - $26.22 $1.96 Million - $2.55 Million
97,115 Added 365.29%
123,701 $3.12 Million
Q1 2023

May 11, 2023
BUY
$20.23 - $26.22 $1.96 Million - $2.55 Million
97,115 Added 365.29%
123,701 $3.12 Million
Q4 2022

May 14, 2024
SELL
$20.54 - $24.67 $115,886 - $139,188
-5,642 Reduced 17.51%
26,586 $611,000
Q4 2022

Feb 13, 2023
SELL
$20.54 - $24.67 $115,886 - $139,188
-5,642 Reduced 17.51%
26,586 $611,000
Q3 2022

May 14, 2024
BUY
$14.71 - $24.18 $271,311 - $445,975
18,444 Added 133.81%
32,228 $711,000
Q3 2022

Nov 10, 2022
BUY
$14.71 - $24.18 $271,311 - $445,975
18,444 Added 133.81%
32,228 $711,000
Q2 2022

May 14, 2024
SELL
$12.93 - $20.29 $4.39 Million - $6.89 Million
-339,738 Reduced 96.1%
13,784 $198,000
Q2 2022

Aug 15, 2022
BUY
$12.93 - $20.29 $581 - $913
45 Added 0.33%
13,784 $198,000
Q1 2022

May 16, 2022
BUY
$16.73 - $21.58 $229,853 - $296,487
13,739 New
13,739 $260,000

Others Institutions Holding TMCI

# of Institutions
138
Shares Held
38.1M
Call Options Held
52K
Put Options Held
19.1K
View Full List

About TREACE MEDICAL CONCEPTS, INC.

TMCI Quotes by TradingView
  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $519M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email